Evaluation of the effect of storage condition on cell extraction and flow cytometric analysis from intestinal biopsies.
暂无分享,去创建一个
C. Buskens | L. Stitt | B. Feagan | V. Jairath | M. Duijvestein | L. Westera | M. Wildenberg | N. Vande Casteele | J. V. D. van der Bilt | T. van Viegen
[1] J. Paul Robinson,et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies. , 2017, European journal of immunology.
[2] R. Owens,et al. Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease , 2017, Nature Medicine.
[3] S. Vermeire,et al. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis , 2017, The New England journal of medicine.
[4] M. Silverberg,et al. Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study , 2017, Clinical and Translational Gastroenterology.
[5] M. McElrath,et al. Cryopreservation of Human Mucosal Leukocytes , 2016, bioRxiv.
[6] S. Vermeire,et al. Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis. , 2016, The New England journal of medicine.
[7] Ruth R. Montgomery,et al. CyTOF supports efficient detection of immune cell subsets from small samples. , 2014, Journal of immunological methods.
[8] Ming Yan,et al. Validation of cell‐based fluorescence assays: Practice guidelines from the ICSH and ICCS – part V – assay performance criteria , 2013, Cytometry. Part B, Clinical cytometry.
[9] P. Rutgeerts,et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. , 2013, The New England journal of medicine.
[10] Kristin Stephens,et al. Vedolizumab as induction and maintenance therapy for Crohn's disease. , 2013, The New England journal of medicine.
[11] C. Mulder,et al. Changes in Natural Foxp3+Treg but Not Mucosally-Imprinted CD62LnegCD38+Foxp3+Treg in the Circulation of Celiac Disease Patients , 2013, PloS one.
[12] M. Altfeld,et al. Standardization of cytokine flow cytometry assays , 2005, BMC Immunology.
[13] P. Rutgeerts,et al. Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease. , 2016, The New England journal of medicine.